Arcellx Ownership
| ACLX Stock | USD 71.31 1.04 1.48% |
Arcellx Stock Ownership Analysis
About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.99. Arcellx had not issued any dividends in recent years. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland. Arcellx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 78 people. For more info on Arcellx please contact Rami Elghandour at 240 327 0630 or go to https://www.arcellx.com.Besides selling stocks to institutional investors, Arcellx also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Arcellx's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Arcellx's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Arcellx Quarterly Liabilities And Stockholders Equity |
|
Arcellx Insider Trades History
About 15.0% of Arcellx are currently held by insiders. Unlike Arcellx's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Arcellx's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Arcellx's insider trades
Arcellx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Arcellx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arcellx backward and forwards among themselves. Arcellx's institutional investor refers to the entity that pools money to purchase Arcellx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | T. Rowe Price Investment Management,inc. | 2025-03-31 | 1.7 M | Hhg Plc | 2025-03-31 | 1.5 M | Cormorant Asset Management, Llc | 2025-03-31 | 1.1 M | Aju Ib Investment Co Ltd | 2025-06-30 | 1 M | Geode Capital Management, Llc | 2025-03-31 | 1 M | Citadel Advisors Llc | 2025-03-31 | 726.1 K | Capital World Investors | 2025-03-31 | 709.4 K | Jpmorgan Chase & Co | 2025-03-31 | 683.6 K | Lord, Abbett & Co Llc | 2025-03-31 | 664.5 K | Fmr Inc | 2025-03-31 | 6.3 M | Paradigm Biocapital Advisors Lp | 2025-03-31 | 4.5 M |
Arcellx Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arcellx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arcellx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arcellx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arcellx Outstanding Bonds
Arcellx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Arcellx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Arcellx bonds can be classified according to their maturity, which is the date when Arcellx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| ARCHER DANIELS MIDLAND 75 Corp BondUS039483AM40 | View | |
| US039483AN23 Corp BondUS039483AN23 | View | |
| ARCHER DANIELS MIDLAND 25 Corp BondUS039483BL57 | View | |
| ARCHER DANIELS MIDLAND 45 Corp BondUS039483BQ45 | View | |
| ARCHER DANIELS MIDLAND 4535 Corp BondUS039483BE15 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Arcellx Corporate Filings
F4 | 11th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 28th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 15th of May 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Arcellx Stock Analysis
When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.